Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Thermo Fisher, Neogen, Gencove, Mawi DNA Technologies

Thermo Fisher Scientific QuantStudio 7 Pro Dx Real-Time PCR System 384-Well Option

Thermo Fisher Scientific has launched a 384-well option for its Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System. The company originally launched the instrument in the US last November with a 96-well block. With the new option, users can easily switch between 96-well and 384-well blocks in order to change the throughput of their assays as needed.


Neogen and Gencove InfiniSeek Cattle WGS and Genotyping Solution

Neogen and Gencove have launched InfiniSeek, a cattle whole-genome sequencing and genotyping solution. The assay simultaneously yields low-pass whole-genome sequencing and high-coverage genotyping at preselected loci in a single molecular reaction, providing information on genomic sequence, specific genetic traits, and parentage markers. It has been validated to show more than 99 percent concordance with deep WGS. Pricing was not disclosed.


Mawi DNA Technologies NextSwab

Mawi DNA Technologies has launched NextSwab, a plastic swab for high-efficiency nasal sample collection. The company released this product in response to the COVID-19 swab shortage. The swab head has two channels, separated by a septum, that retain the collected nasal material. This can then be released into transport medium with a gentle shake. The swab is compatible with many sample transport tubes and does not require any preparation for specimen collection. It fully releases its contents into the sample transport medium.


For more new products and services, please visit the New Products page on our website.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.